With an oversubscribed trading debut now in the books, Veradermics—developing an oral version of the molecule behind ...
Zhengye receives a Nasdaq notice for failing to file its 2024 annual report on time. The company has 60 days to submit a compliance plan to avoid potential delisting. Get special access to three ...
I favor biotech stocks trading below cash value after setbacks; Arvinas (ARVN) fits this description, dropping 25% on Thursday after ending two Phase 3 trials. ARVN's net cash per share is over $12, ...
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
TRINITY BIOTECH ($TRIB) is expected to release its quarterly earnings data on Thursday, May 22nd before market open, per Finnhub. Analysts are expecting revenue of ...
(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a ...
An increasingly important element of payments made in merger deals in the biotech industry has significant drawbacks: Financial instruments meant to reward shareholders if a target company’s drugs ...
09:35 EDT Zhengye Biotechnology (ZYBT) Holding Ltd trading halted, volatility trading pause Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor ...
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report)‘s stock had its “hold” rating reissued by research analysts at Jones Trading in a report released on Friday,Benzinga reports. Several other equities ...
Kane Biotech Inc. (CVE:KNE – Get Free Report) shares fell 23.1% during mid-day trading on Saturday . The stock traded as low as C$0.05 and last traded at C$0.05. 159,625 shares changed hands during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results